Reliant Pharmaceuticals Report issue

For profit Phase 4
Founded: Liberty Corner NJ United States (1999)
Status: Acquired by GlaxoSmithKline (2008)

Organization Overview

First Clinical Trial
2006
NCT00454493
First Marketed Drug
2007
omega-3 fatty acids (Omacor)
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

RELIANT PHARMS

Active Ingredients

Marketed Drugs (1)

omega-3 fatty acids (Omacor) (2007)

Drugs in Phase 4 Trials (2)

icosapent ethyl (vascepa) (9 trials)

simvastatin (zocor) (2 trials)

Drugs in Other Trials (1)

corn (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Dyslipidemias (Phase 4)

Hemorrhage (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 3